- Home
- AVTX vs FGBI Comparison
AVTX vs FGBI Comparison
Compare AVTX & FGBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- FGBI
- Stock Information
- Founded
- AVTX 2011
- FGBI 1934
- Country
- AVTX United States
- FGBI United States
- Employees
- AVTX N/A
- FGBI N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- FGBI Savings Institutions
- Sector
- AVTX Health Care
- FGBI Finance
- Exchange
- AVTX Nasdaq
- FGBI Nasdaq
- Market Cap
- AVTX 118.6M
- FGBI 121.5M
- IPO Year
- AVTX 2015
- FGBI N/A
- Fundamental
- Price
- AVTX $9.88
- FGBI $7.84
- Analyst Decision
- AVTX Strong Buy
- FGBI
- Analyst Count
- AVTX 8
- FGBI 0
- Target Price
- AVTX $31.00
- FGBI N/A
- AVG Volume (30 Days)
- AVTX 335.9K
- FGBI 3.6K
- Earning Date
- AVTX 08-07-2025
- FGBI 08-18-2025
- Dividend Yield
- AVTX N/A
- FGBI 0.50%
- EPS Growth
- AVTX N/A
- FGBI N/A
- EPS
- AVTX N/A
- FGBI N/A
- Revenue
- AVTX $441,000.00
- FGBI $59,070,000.00
- Revenue This Year
- AVTX N/A
- FGBI N/A
- Revenue Next Year
- AVTX N/A
- FGBI $3.38
- P/E Ratio
- AVTX N/A
- FGBI N/A
- Revenue Growth
- AVTX N/A
- FGBI N/A
- 52 Week Low
- AVTX $3.39
- FGBI $6.56
- 52 Week High
- AVTX $16.00
- FGBI $15.25
- Technical
- Relative Strength Index (RSI)
- AVTX 76.24
- FGBI 40.14
- Support Level
- AVTX $8.41
- FGBI $7.70
- Resistance Level
- AVTX $9.80
- FGBI $8.08
- Average True Range (ATR)
- AVTX 0.85
- FGBI 0.19
- MACD
- AVTX -0.01
- FGBI -0.03
- Stochastic Oscillator
- AVTX 87.52
- FGBI 19.67
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About FGBI First Guaranty Bancshares Inc.
First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.